Farmoz Rodex B Rodenticide Pellets

Adama Australia Pty Ltd

Revision date : 2012-08-01

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 4
Safety risk rating 1
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

56073-10-0

Name of the chemical

Brodifacoum (ISO); 4-Hydroxy-3-(3-(4′-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)cumarin (2016/1179)

Concentration

100%

General Information

Revision date

2012-08-01

Product name

Farmoz Rodex B Rodenticide Pellets

CAS No.

56073-10-0

1.2.1 Relevant identified uses

Rodenticide for use as described on the product label

Icons in SDS

M004 M009 M010 M011 M017 GHS07

Company Information

company name

Adama Australia Pty Ltd

Section 2

SECTION 2: Hazards identification

Hazard statements

This product is classified as: Hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. R22. Harmful if swallowed

Precautionary statements

S2, S20. Keep out of reach of children. When using, do not eat or drink

SUSMP Classification

S6

ADG classification

None allocated. Not a Dangerous Good

UN Number

None allocated Emergency Overview Physical Description & colour: Blue pellets. Odour: Mild odour.

Health hazards

Ingestion of Brodifacoum is initially asymptomatic, and may continue as such even with prolonged alterations in prothrombin time. No gastrointestinal tract or other symptomatology occurs. Coagulation disturbances may become evident a few days after ingestion, and may be detected only by laboratory studies. In severe poisoning, gum-bleeding, epistaxis, petechiae, ecchymoses, haematomata, blood in urine and faeces, and genital haemorrhage may occur. Internal bleeding and cerebral haemorrhage may complicate the patient's prognosis. No major health hazards are known.

Potential health effects

See section 11 for Chronic exposure studies. Inhalation Short term exposure: Available data indicates that this product is not harmful. In addition, this product may be mildly irritating, but is unlikely to cause anything more than mild transient discomfort. Skin Contact: Short term exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition, this product is unlikely to cause any discomfort in normal use. Eye Contact: Short term exposure: Available data shows that this product is not harmful. Ingestion: Short term exposure: This product is harmful if swallowed. See symptoms above. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.